RDX BIOSCIENCE Trademark

Trademark Overview

On Thursday, August 9, 2018, a trademark application was filed for RDX BIOSCIENCE with the United States Patent and Trademark Office. The USPTO has given the RDX BIOSCIENCE trademark a serial number of 88072025. The federal status of this trademark filing is REGISTERED as of Tuesday, March 10, 2020. This trademark is owned by Tenet Diagnostics Inc.. The RDX BIOSCIENCE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnostic drug testing for substance abuse, and medical diagnostic genetic testing
rdx bioscience

General Information

Serial Number88072025
Word MarkRDX BIOSCIENCE
Filing DateThursday, August 9, 2018
Status700 - REGISTERED
Status DateTuesday, March 10, 2020
Registration Number6008738
Registration DateTuesday, March 10, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and ServicesMedical diagnostic drug testing for substance abuse, and medical diagnostic genetic testing
NOT AVAILABLE"BIOSCIENCE"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 16, 2018
Primary Code044
First Use Anywhere DateSaturday, September 1, 2018
First Use In Commerce DateSaturday, September 1, 2018

Trademark Owner History

Party NameTenet Diagnostics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKenilworth, NJ 07033
Party NameTenet Diagnostics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKenilworth, NJ 07033
Party NameTenet Diagnostics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKenilworth, NJ 07033

Trademark Events

Event DateEvent Description
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Monday, August 13, 2018NEW APPLICATION ENTERED
Thursday, August 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 1, 2019FINAL REFUSAL E-MAILED
Monday, April 1, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 6, 2018NON-FINAL ACTION WRITTEN
Thursday, December 6, 2018NON-FINAL ACTION E-MAILED
Thursday, December 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2019ASSIGNED TO LIE
Monday, March 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2019FINAL REFUSAL WRITTEN
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 18, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, April 18, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, April 18, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 18, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, April 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 15, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, February 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 10, 2020REGISTERED-PRINCIPAL REGISTER
Monday, March 10, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 6, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 15, 2020USE AMENDMENT FILED
Tuesday, February 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 5, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

bioscience medical testing diagnostic genetic abuse substance drug